A new drug, NXP800, shows promise in treating hormone therapy-resistant prostate cancer by targeting the Heat Shock Factor 1 (HSF1) pathway, which supports cancer cell growth.

Discover top medications for 'treating Prostate Cancer'? This page compiles essential information on generic and brand-name drugs specifically used for Prostate Cancer treatment.Here, you can ...

The US Food and Drug Administration has approved the drug Xtandi (enzalutamide) to treat men with advanced non-metastatic prostate cancer. This follows a ‘priority review’ designation ...

In the lab, the researchers found that NXP800 slowed the growth of prostate cancer cells—even for cells which were resistant to the hormone therapy enzalutamide. In biopsies of patients with ...

"Prostate cancer: Three drug trials to watch" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this site has been included in good faith ...

Discover top medications for 'treating Prostate Biopsy'? This page compiles essential information on generic and brand-name drugs specifically used for Prostate Biopsy treatment.Here, you can ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research published in ...

but their optimal use—such as which drug or drug combinations should be used first to achieve the best outcomes from prostate cancer treatment—is still being worked out. Nevertheless ...

Scientists are trialling an innovative new drug that could offer hope to patients with advanced prostate cancer, particularly those for whom current treatments have ceased to be effective.

The new urine test looks at 18 genes that are linked to high-risk prostate cancer. Previous research showed that MPS2 could ...